These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11761152)

  • 1. The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.
    Chirila TV; Rakoczy PE; Garrett KL; Lou X; Constable IJ
    Biomaterials; 2002 Jan; 23(2):321-42. PubMed ID: 11761152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The delivery of antisense therapeutics.
    Akhtar S; Hughes MD; Khan A; Bibby M; Hussain M; Nawaz Q; Double J; Sayyed P
    Adv Drug Deliv Rev; 2000 Oct; 44(1):3-21. PubMed ID: 11035194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on polymethacrylate nanoparticles as delivery system of antisense oligodeoxynucleotides].
    Wang WX; Chen HL; Liang WQ
    Yao Xue Xue Bao; 2003 Apr; 38(4):298-301. PubMed ID: 12889133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic hydrogels as carriers in antisense therapy: preliminary evaluation of an oligodeoxynucleotide covalent conjugate with a copolymer of 1-vinyl-2-pyrrolidinone and 2-hydroxyethyl methacrylate.
    Lou X; Garrett KL; Rakoczy PE; Chirila TV
    J Biomater Appl; 2001 Apr; 15(4):307-20. PubMed ID: 11336385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes as a drug delivery system for antisense oligonucleotides.
    Juliano RL; Akhtar S
    Antisense Res Dev; 1992; 2(2):165-76. PubMed ID: 1392538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid conjugated oligonucleotides: a useful strategy for delivery.
    Raouane M; Desmaële D; Urbinati G; Massaad-Massade L; Couvreur P
    Bioconjug Chem; 2012 Jun; 23(6):1091-104. PubMed ID: 22372953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
    Fattal E; Bochot A
    Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.
    Lewis JG; Lin KY; Kothavale A; Flanagan WM; Matteucci MD; DePrince RB; Mook RA; Hendren RW; Wagner RW
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3176-81. PubMed ID: 8622909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro delivery of antisense oligonucleotides.
    Jääskeläinen I; Honkakoski P; Urtti A
    Cell Mol Biol Lett; 2002; 7(2):236-7. PubMed ID: 12097930
    [No Abstract]   [Full Text] [Related]  

  • 12. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides.
    Thierry AR; Rahman A; Dritschilo A
    Biochem Biophys Res Commun; 1993 Feb; 190(3):952-60. PubMed ID: 8094959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of antisense oligonucleotides: a brief review of current strategies.
    Zhao X; Pan F; Holt CM; Lewis AL; Lu JR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):673-86. PubMed ID: 19552611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
    Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
    Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo.
    Wang M; Wu B; Tucker JD; Shah SN; Lu P; Lu Q
    J Nanobiotechnology; 2020 Feb; 18(1):34. PubMed ID: 32070342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes.
    Jia N; Lian Q; Shen H; Wang C; Li X; Yang Z
    Nano Lett; 2007 Oct; 7(10):2976-80. PubMed ID: 17725375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
    Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
    Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
    Aoki Y; Kawa S; Karasawa Y; Horiuchi A; Kiyosawa K
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):702-5. PubMed ID: 9750959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
    Hu Q; Shew CR; Bally MB; Madden TD
    Biochim Biophys Acta; 2001 Sep; 1514(1):1-13. PubMed ID: 11513800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel graft copolymers enhance in vitro delivery of antisense oligonucleotides in the presence of serum.
    Peddada LY; Harris NK; Devore DI; Roth CM
    J Control Release; 2009 Dec; 140(2):134-40. PubMed ID: 19699243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.